18 hours ago · In conclusion, we have described a case of cardiovascular crisis which took place after a small amount of epinephrine was injected in a healthy patient without any heart disease. The complex cardiovascular interactions of treatment with β-blockers and, possibly, lidocaine, must be appreciated in order to prevent severe complications such as pulmonary edema and cardiac arrest. >> Go To The Portal
After local application of 0.01% epinephrine-soaked nasal pledgets and infiltration of 3 mL 0.001% epinephrine, the patient developed a severe hypertension of 205/126 mmHg, followed by ventricular tachycardia. Cardiac arrest ensued after intravenous injection of lidocaine and esmolol in an attempt to control ventricular arrhythmia.
Full Answer
In conclusion, we have described a case of cardiovascular crisis which took place after a small amount of epinephrine was injected in a healthy patient without any heart disease.
Ristagno G, Tang W, Huang L, Fymat A, Chang YT, Sun S, et al. Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation. Crit Care Med. 2009;37:1408–1415. [ PubMed] [ Google Scholar] 18.
While epinephrine use has been shown to increase the chance of ROSC in OHCA, it has not been shown to improve survival to hospital discharge nor neurologic outcome. It is important to recognize that these studies do not necessarily conclude that epinephrine should not be used in cardiac arrest.
Some cited papers showing higher doses and earlier administration of epinephrine in cardiac arrest increasing ROSC rates, while others cited papers showing lower doses improving cerebral perfusion pressure.
A further risk to the cardiac patient is the ability of epinephrine to irritate cardiac pacemaker cells and cause dysrhythmias. Thus, the injudicious use of epinephrine can be harmful to a patient with cardiac disease.
Hence, epinephrine causes constriction in many networks of minute blood vessels but dilates the blood vessels in the skeletal muscles and the liver. In the heart, it increases the rate and force of contraction, thus increasing the output of blood and raising blood pressure.
Summary: For patients in cardiac arrest, administering epinephrine helps to restart the heart but may increase the overall likelihood of death or debilitating brain damage, according to a study.
The maximum dose of epinephrine in local anaesthesia for a healthy subject is 0.2 mg, though this can be lowered to 0.04 mg if patient has severe cardiovascular disease (ASA III and IV) [11].
There are no absolute contraindications against using epinephrine. Some relative contraindications include hypersensitivity to sympathomimetic drugs, closed-angle glaucoma, anesthesia with halothane. Another unique contraindication to be aware of is catecholaminergic polymorphic ventricular tachycardia.
The decrease in rate seen on rare occasions was never more than 15%. There was no significant difference in average heart rates within age groups either before or after administration of epinephrine (Fig.
Epinephrine overdosage can also cause transient bradycardia followed by tachycardia and these may be accompanied by potentially fatal cardiac arrhythmias. Premature ventricular contractions may appear within one minute after injection and may be followed by multifocal ventricular tachycardia (prefibrillation rhythm).
Adrenaline injections have been commonly used during CPR for cardiac arrest for more than 60 years, without clear evidence if it is helpful or harmful. Adrenaline can increase the likelihood that the heart will regain a normal rhythm as it directs blood flow to the heart.
Addition of adrenaline to local anaesthetic solution is contraindicated for the following diseases like heart diseases, untreated or uncontrolled severe hypertension, uncontrolled hyperthyroidism, uncontrolled diabetes etc.
According to the literature reviewed, the use of 1 to 2 cartridges of local anesthetics with 1:80,000, 1:100,000 or 1:200,000 epinephrine in patients with controlled Hypertension and/ or Coronary disease is safe.
The added risks attributed to the use of epinephrine in hypertensive patients include: Through the direct action of epinephrine-greater probability of acute hypertensive crisis (dangerously high blood pressure), angina pectoris and myocardial infarction, as well as cardiac arrthymias.
In medicine epinephrine is used chiefly as a stimulant in cardiac arrest, as a vasoconstrictor in shock, and as a bronchodilator and antispasmodic in bronchial asthma.
Epinephrine acts on the heart, increasing the heart rate and force of contraction, and increasing blood pressure. It stimulates electrical and mechanical activity, producing myocardial contractility.
Adrenaline (epinephrine) reacts with both α- and β-adrenoceptors, causing vasoconstriction and vasodilation, respectively.
Epinephrine and norepinephrine are similar chemicals that act as both neurotransmitters and hormones in the body. Both substances play an important role in the body's fight or flight response, and their release into the bloodstream causes increases in blood pressure, heart rate, and blood sugar levels.
Epinephrine or “adrenaline” is a hormone that is naturally made by the human body which serves many functions. One function is to raise heart rate and blood pressure. Doctors also use epinephrine as a medication to raise blood pressure when someone's blood pressure is very low.
Epinephrine is commonly used in nasal surgeries to decrease bleeding in the operative site. If locally administrated epinephrine reaches the systemic circulation, however it can cause hypertensive crisis, arrhythmia, pulmonary edema and even cardiac arrest ( 1 ).
A 28-year-old man, weighing 62 kg, was admitted for nasal septoplasty. The patient denies has any history of hypertension or cardiac disease family history, and there was no evidence of cardiac or pulmonary disease on physical and laboratory examination.
A local infiltration of epinephrine mixed with saline or local anesthetic is widely used to improve the surgical field view, provide hemostasis or diminish the systemic toxic effect of local anesthetic. However, absorption or inadvertent intravascular injection of epinephrine might cause unexpected cardiovascular effects ( 1 ).
Funding: This research was supported by the National Natural Science Foundation of China (Grant no. 81701116).
Reporting Checklist: The authors have completed the CARE reporting checklist. Available at http://dx.doi.org/10.21037/acr-20-161
For patients in cardiac arrest, administering epinephrine helps to restart the heart but may increase the overall likelihood of death or debilitating brain damage, according to a study published Dec. 1 the Journal of the American College of Cardiology.
Dumas notes that this study underscores the need for caution when using epinephrine. Administering epinephrine to patients in cardiac arrest has been shown to improve ROSC, but the new study adds to mounting evidence suggesting the drug harms patients’ chances of surviving past the post-resuscitation period with brain function intact.
Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. The New England journal of medicine. 2018; 379:711-721.
REBEL EM on Beyond ACLS: Is It Time to Abandon Epinephrine in Out-Of-Hospital Cardiac Arrest?